弘信电子(300657.SZ):股东何建顺累计减持41万股 减持计划提前结束
格隆汇 12 月 30日丨弘信电子(300657.SZ)公布,近日,公司收到股东何建顺(董事孔志宾之配偶)出具的《关于减持计划数量过半暨减持计划提前结束的告知函》,截至目前,股东何建顺已披露的减持计划中设定的减持数量已过半,并决定提前结束此次减持计划,此次减持计划剩余未减持股份在此次减持计划期限内不再实施,此次其累计减持41万股,占剔除回购专用账户股份后总股本比例0.12%。
Follow us
Find us on 
Facebook, 
Twitter , 
Instagram, and 
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the 
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.